Search Within

Linda Su Hyun Ahn

  1. "Tow Center for Developmental Oncology (TCDO) "
Formats
  1. Journal Article (9)
  2. Meeting Abstract (1)
Groups
  1. Department of Medicine (10)
  2. Department of Pathology and Laboratory Medicine (10)
  3. GSK Faculty (10)
  4. Nursing (10)
  5. Solid Tumor Oncology Division (10)
  6. Tow Center for Developmental Oncology (TCDO) (10)

More Groups

People
  1. Marc Ladanyi (5)
  2. Mark Kris (5)
  3. Cristina Antonescu (4)
  4. Gregory Riely (4)
  5. Helena Yu (4)
  6. Mary Keohan (4)

More People

Years
  1. 2023 (2)
  2. 2022 (2)
  3. 2020 (1)
  4. 2019 (2)
  5. 2011 (1)
  6. 2010 (2)
Publications
  1. Clinical Cancer Research (2)
  2. Cancer (1)
  3. Cold Spring Harbor Molecular Case Studies (1)
  4. JAMA Oncology (1)
  5. JTO Clinical and Research Reports (1)
  6. Journal of Clinical Oncology (1)

More Publications

Publishers
  1. American Association for Cancer Research (2)
  2. American Medical Association (1)
  3. American Society of Clinical Oncology (1)
  4. Cold Spring Harbor Laboratory Press (1)
  5. Elsevier BV (1)
  6. Elsevier Inc. (1)

More Publishers

Results (10)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Targeting NFE2L2/KEAP1 mutations in advanced NSCLC with the TORC1/2 inhibitor TAK-228
    Journal Article

    Paik, P. K.; Fan, P. D.; Qeriqi, B.; Namakydoust, A.; Daly, B.; Ahn, L.; Kim, R.; Plodkowski, A.; Ni, A.; Chang, J.; more...
    Journal of Thoracic Oncology (2023)

    Fulltext@MSK | Save
  • Brief report: Combination of osimertinib and dacomitinib to mitigate primary and acquired resistance in EGFR-mutant lung adenocarcinomas
    Journal Article

    Elkrief, A.; Makhnin, A.; Moses, K. A.; Ahn, L. S.; Preeshagul, I. R.; Iqbal, A. N.; Hayes, S. A.; Plodkowski, A. J.; Paik, P. K.; Ladanyi, M.; more...
    Clinical Cancer Research (2023)

    Fulltext@MSK | Save
  • Phase I trial of the TNF-α inhibitor certolizumab plus chemotherapy in stage IV lung adenocarcinomas
    Journal Article

    Paik, P. K.; Luo, J.; Ai, N.; Kim, R.; Ahn, L.; Biswas, A.; Coker, C.; Ma, W.; Wong, P.; Buonocore, D. J.; more...
    Nature Communications (2022)

    Fulltext@MSK | Save
  • Phase 1 clinical trial of trametinib and ponatinib in patients with NSCLC harboring KRAS mutations
    Journal Article

    Arbour, K. C.; Manchado, E.; Bott, M. J.; Ahn, L.; Tobi, Y.; Ni, A. A.; Yu, H. A.; Shannon, A.; Ladanyi, M.; Perron, V.; more...
    JTO Clinical and Research Reports (2022)

    Fulltext@MSK | Save
  • Effect of osimertinib and bevacizumab on progression-free survival for patients with metastatic EGFR-mutant lung cancers: A phase 1/2 single-group open-label trial
    Journal Article

    Yu, H. A.; Schoenfeld, A. J.; Makhnin, A.; Kim, R.; Rizvi, H.; Tsui, D.; Falcon, C.; Houck-Loomis, B.; Meng, F.; Yang, J. L.; more...
    JAMA Oncology (2020)

    Fulltext@MSK | Save
  • A phase II trial of sorafenib and dacarbazine for leiomyosarcoma, synovial sarcoma, and malignant peripheral nerve sheath tumors
    Journal Article

    D'Adamo, D. R.; Dickson, M. A.; Keohan, M. L.; Carvajal, R. D.; Hensley, M. L.; Hirst, C. M.; Ezeoke, M. O.; Ahn, L.; Qin, L. X.; Antonescu, C. R.; more...
    The Oncologist (2019)

    Fulltext@MSK | Save
  • Exceptional responders with invasive mucinous adenocarcinomas: A phase 2 trial of bortezomib in patients with KRAS G12D-mutant lung cancers
    Journal Article

    Drilon, A.; Schoenfeld, A. J.; Arbour, K. C.; Litvak, A.; Ni, A.; Montecalvo, J.; Yu, H. A.; Panora, E.; Ahn, L.; Kennedy, M.; more...
    Cold Spring Harbor Molecular Case Studies (2019)

    Fulltext@MSK | Save
  • Activity of sorafenib against desmoid tumor/deep fibromatosis
    Journal Article

    Gounder, M. M.; Lefkowitz, R. A.; Keohan, M. L.; D'adamo, D. R.; Hameed, M.; Antonescu, C. R.; Singer, S.; Stout, K.; Ahn, L.; Maki, R. G.
    Clinical Cancer Research (2011)

    Fulltext@MSK | Save
  • Activity of sorafenib against desmoid tumor/deep fibromatosis (DT/DF)
    Meeting Abstract

    Gounder, M. M.; Antonescu, C.; Hameed, M. R.; D'Adamo, D. R.; Keohan, M.; Singer, S.; Brennan, M. F.; Ahn, L. S.; Maki, R. G.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • Clinical outcomes of systemic therapy for patients with deep fibromatosis (desmoid tumor)
    Journal Article

    de Camargo, V. P.; Keohan, M. L.; D'adamo, D. R.; Antonescu, C. R.; Brennan, M. F.; Singer, S.; Ahn, L. S.; Maki, R. G.
    Cancer (2010)

    Fulltext@MSK | Save